Dr. George M. Matuschak, MD

Dr. Matuschak practices at Mercy Clinic Pulmonology - St. Louis in Saint Louis, Missouri.

Dr. Matuschak's NPI, 1881780021, was assigned on October 5, 2006. Dr. Matuschak graduated from Lewis Katz School of Medicine in 1977. Dr. Matuschak holds Missouri license R3H17.

Dr. Matuschak's primary practice is Mercy Clinic Pulmonology - St. Louis, at 621 S New Ballas Rd, Saint Louis, MO 63141 in Saint Louis County. The practice phone is (314) 251-4966.

Dr. Matuschak's primary practice is Mercy Clinic Pulmonology - St. Louis in Saint Louis, Missouri. Dr. Matuschak is also affiliated with Mercy Hospital St. Louis. The medical group on file is Mercy Hospital St. Louis. Dmand AI also links Dr. Matuschak to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matuschak practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Matuschak's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Matuschak is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Matuschak's licenses on file in 2 states: Missouri and Pennsylvania.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Matuschak treats.

CMS data shows 1,025 Medicare services from Dr. Matuschak across 14 procedure codes in 2024, for 525 Medicare patients. Medicare paid $66,784 for them.

CMS counts 525 Medicare patients who saw Dr. Matuschak in 2024. The largest group is 65 to 74, with 249 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Matuschak's median patient age at 69, with 54% women.

In 2024, Dr. Matuschak wrote 5,493 Medicare Part D claims for 591 patients. 58% of them were for generic drugs. CMS names the drug for 5,300 of them, across 70 drugs with 11 or more claims each, at $6,970,676 in total drug cost. In 2023, CMS named 4,566 claims across 68 drugs.

Dr. Matuschak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Matuschak as offering telehealth.

Dmand AI links 48 papers to Dr. Matuschak, published from 2002 to 2017. 2010 was the busiest year, with 3. The most frequent topics are Rats, Sprague-Dawley, Liver and Tumor Necrosis Factor-alpha. Dr. Matuschak has published most often in Am J Physiol. Dr. Matuschak's most frequent co-authors are Timothy Eugene Albertson, MD, MPH, PhD, Salvador Cruz-Flores, MD and Dayton E. Dmello, MD.

Dmand AI links Dr. Matuschak to 2 clinical trials. Conditions studied include COVID-19, Pulmonary Arterial Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 111 general payments to Dr. Matuschak from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $11,766.

Dmand AI lists 4 awards for Dr. Matuschak, most recently America's Top Doctors in 2023.

Dr. Matuschak graduated from Lewis Katz School of Medicine in 1977. Dr. Matuschak is a member of AOA, AASM, ACCP, SCCM, ATS and Pulmonary Hypertension Association.

Dr. Matuschak is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.